Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy Roemhild

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|August 19, 2015
Virus-specific T-cell therapy in solid organ transplantationAndy Roemhild, Petra Reinke
Frontiers in Cell and Developmental Biology|February 16, 2023
Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospectiveLeila Amini, Jaspal Kaeda, Enrico Fritsche, et al.
Kidney International|May 25, 2018
Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapySybille Landwehr-Kenzel, Anne Zobel, Henrike Hoffmann, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 10, 2009
Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapyGordon Brestrich, Sandra Zwinger, Andy Roemhild, et al.
European Journal of Immunology|March 17, 2010
Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsetsManuel Guerreiro, Il-Kang Na, Anne Letsch, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafetyMarkus H Hammer, Gordon Brestrich, Alexa Mittenzweig, et al.
Frontiers in Cell and Developmental Biology|December 20, 2021
Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products <i>ex vivo</i> and <i>in vivo</i>Daniel Kaiser, Natalie Maureen Otto, Oliver McCallion, et al.
Frontiers in Cell and Developmental Biology|December 6, 2021
Strong Expansion of Human Regulatory T Cells for Adoptive Cell Therapy Results in Epigenetic Changes Which May Impact Their Survival and FunctionKristy Ou, Dania Hamo, Anne Schulze, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2022
Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHDSybille Landwehr-Kenzel, Leonie Müller-Jensen, Joern-Sven Kuehl, et al.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Transplant International : Official Journal of the European Society for Organ Transplantation|August 19, 2015
Virus-specific T-cell therapy in solid organ transplantationAndy Roemhild, Petra Reinke
Frontiers in Cell and Developmental Biology|February 16, 2023
Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospectiveLeila Amini, Jaspal Kaeda, Enrico Fritsche, et al.
Kidney International|May 25, 2018
Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapySybille Landwehr-Kenzel, Anne Zobel, Henrike Hoffmann, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 10, 2009
Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapyGordon Brestrich, Sandra Zwinger, Andy Roemhild, et al.
European Journal of Immunology|March 17, 2010
Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsetsManuel Guerreiro, Il-Kang Na, Anne Letsch, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafetyMarkus H Hammer, Gordon Brestrich, Alexa Mittenzweig, et al.
Frontiers in Cell and Developmental Biology|December 20, 2021
Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products <i>ex vivo</i> and <i>in vivo</i>Daniel Kaiser, Natalie Maureen Otto, Oliver McCallion, et al.
Frontiers in Cell and Developmental Biology|December 6, 2021
Strong Expansion of Human Regulatory T Cells for Adoptive Cell Therapy Results in Epigenetic Changes Which May Impact Their Survival and FunctionKristy Ou, Dania Hamo, Anne Schulze, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2022
Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHDSybille Landwehr-Kenzel, Leonie Müller-Jensen, Joern-Sven Kuehl, et al.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
Pageof 2